logo
Effort to make ‘intentional exposure' to STDs a crime in Louisiana fails

Effort to make ‘intentional exposure' to STDs a crime in Louisiana fails

Yahoo09-05-2025

Rep. Patricia Moore, D-Monroe, at the Louisiana State Capitol on Wednesday, May 7, 2025. (John Gray/Verite News)
A Louisiana House committee shelved a bill Wednesday that would have made it illegal for someone to 'intentionally' expose another person to an 'incurable' sexually transmitted disease after steep concerns that criminalization could worsen the state's proliferating STD rates.
This was the second time Rep. Patricia Moore, D-Monroe, had introduced such a bill in five years, despite opposition from public and sexual health advocates as well as people living with STDs. Moore said at a House Administration of Criminal Justice committee meeting that she wants to create a law that offers people recourse for when someone 'knowingly and intentionally' doesn't disclose their STD status.
The bill would have created a new felony, carrying up to 10 years in prison and $5,000 in fines, for someone who knows they have an 'incurable' STD and exposes someone else without their knowledge and consent. Those penalties would have increased if the person exposed to the STD is a minor, over 65 years old or has an intellectual disability. The exposure under either charge would have needed to come through sexual contact, donating bodily fluids such as blood or sharing needles.
After pushback during public testimony, Moore voluntarily deferred House Bill 76.
SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
In 2023, Louisiana had the highest rate of chlamydia cases in the country and ranked in the top 10 for syphilis, HIV and gonorrhea, according to data from the U.S. Centers for Disease Control and Prevention.
The legislation comes as other states have repealed or modernized their own laws criminalizing STDs, especially HIV, over the past decade to align with the current medical landscape. An attempt to update Louisiana's own law criminalizing HIV failed last year.
Before the bill was deferred, Moore amended it to just focus on 'incurable' STDs, removing a proposal to create a new misdemeanor charge for exposing someone to a curable STD. The four most common incurable sexually transmitted infections are hepatitis B, herpes simplex virus (HSV), human papillomavirus (HPV) and HIV. While no treatments exist to eliminate these viruses, all are treatable and manageable with medication, and HPV can sometimes clear up on its own.
But the groups who opposed the bill, including several members of the Louisiana Coalition Against Criminalization and Health, said the bill would have the same problems as another state law on the books that criminalizes 'intentional exposure' to HIV.
In the Deep South, health care fights echo civil rights battles
Data on how many people have been charged under the law is challenging to compile, but UCLA's Williams Institute identified 147 allegations of HIV-related crimes between 2011 and 2022 in Louisiana, though researchers said that number could be higher.
Dietz, the coalition's state coordinator, told the committee that said both the current law and bill contain 'legal loopholes' that allow the law to be used against people living with HIV in their personal relationships, in part because it's on the person living with the STD to prove they received the accuser's consent.
In 2024, Dietz and other members of a state task force charged with researching the criminalization of HIV found that Louisiana's current legal approach 'can actually interfere with work to end the HIV epidemic,' according to its report.
'We've already made recommendations for the way the existing law allows for environments of coercion because again … proving that you disclosed your status is challenging,' Dietz said. 'Even if you were to have proof in your hand, even if someone were to write it down, what if someone ripped it up? Or you lost it?'
St. Tammany Parish resident Katie Darling, who also serves as the vice chair of the Louisiana Democratic Party, shared the testimony of one of her residents who said she had been living with HIV for 25 years. Darling said the resident had her first husband sign an affidavit acknowledging that he knew she had HIV and consented, even though she was taking medication that prevented transmission. When the marriage turned physically abusive, the resident testified that her former husband threatened to take her to court over her HIV status.
'Thankfully, I had the document he signed on file at my doctor's office. But what if I hadn't?' Darling read from the testimony. The St. Tammany resident has now had her second husband sign a similar affidavit.
Those who opposed the bill also acknowledged that there is a need for people to have justice when they are unknowingly given an STD, whether that's under new legislation or current laws around sexual assault.
Jennifer Tokarski, who is living with HPV, testified in support of the bill. She shared the story of her former husband who had sex outside of their marriage, refused to admit it and ultimately transmitted the virus to her.
'After five years in what I believed was a faithful relationship and Catholic marriage, I became severely ill,' Tokarski testified. 'My husband attended appointments, rejected STD testing, reassuring doctors we were monogamous.'
When she learned of his infidelity, she said he battered her and filed for divorce.
'Only then did I learn he had infected me with a lifelong and incurable STD,' Tokarski said. 'This is not just a private betrayal, this is a public health failure.'
Moore and Tokarski said they believed such a law would help promote honest conversations about sexual health that would lower the spread and give survivors a voice.
Studies have shown that criminalizing STDs do little to lower the number of cases and increase stigma. During testimony, public health advocates said Louisiana should invest more heavily in resources for testing and treatment as well as sexual health education, which isn't required in schools.
At Wednesday's meeting, Moore said she planned to work with the bill's opponents to improve the language and possibly return the legislation to the committee if there's time before the session. Otherwise, Moore said she will bring a form of the legislation back next year.
SUPPORT: YOU MAKE OUR WORK POSSIBLE
This article first appeared on Verite News New Orleans and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump to slash funding for flagship US HIV programme by 40pc
Trump to slash funding for flagship US HIV programme by 40pc

Yahoo

time44 minutes ago

  • Yahoo

Trump to slash funding for flagship US HIV programme by 40pc

America is proposing to cut its flagship anti-HIV programme by almost 40 per cent next year, according to new budget details that reveal sweeping reductions to global health spending. Details from Donald Trump's 2026 budget request show nearly a two-fifths fall in funding for the United States President's Emergency Plan for Aids Relief (Pepfar). The long-running programme is estimated to have saved more that 20 million lives in the past two decades, and is often cited as one of the world's most successful public health schemes. A recent analysis published in the Lancet found that as many as half a million more children could die from Aids by the end of the decade because of disruptions to Pepfar. The details on global health funding for the State Department, USAID agency, Centres for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH) also show deep cuts elsewhere. Analysis by the San Francisco-based KFF health policy charity found the government departments were planning a 55 per cent cut in separate tuberculosis funding, a 47 per cent cut in malaria funding and a 92 per cent cut in maternal health funding. The proposal also withdraws all £221m ($300m) given to Gavi, the vaccine alliance which provides jabs to children in poor countries. In total, the request for money for the American government's main global health funding account is £2.8bn ($3.8bn) in 2026, down from £7.4bn ($10bn) in 2025. Setting out the cuts, the State Department said the request for money 'eliminates funding for programmes that do not make Americans safer, such as family planning and reproductive health, neglected tropical diseases, and non-emergency nutrition'. Mr Trump's government upended US aid spending days after taking office, saying it would suspend all aid while projects were reviewed. It then proceeded to close hundreds of aid programmes, including Pepfar projects, resulting in lay-offs for thousands of health workers, particularly in Africa. The budget proposals now give a clear indication that Mr Trump intends to continue with sharp cuts and will quash any hopes that the funding taps could be switched back on again. A State Department explanation of the budget request uses the phrase 'America First' 37 times as it explains a new focus on cutting costs and protecting US national interests. For the 2026 fiscal year, which begins on Oct 1, the budget proposals request £2.1bn ($2.9bn) for Pepfar, a 38 per cent reduction from the £3.5bn ($4.7bn) requested in 2025. The State department said that after spending a total of £88bn ($120bn) in the past two decades, it was now focussing on finding a responsible 'off ramp' to hand over responsibility for the campaign against HIV to countries themselves. 'This [budget] request will allow the United States to accelerate the transition of HIV control programmes to recipient countries and increase international ownership of efforts to fight HIV/Aids.' Some projects may still be paid for by other government funds, but overall the KFF analysis found the budget included 'significant reductions in global health funding including the elimination of some programs and activities'. The details will prove a severe disappointment to aid projects who had hoped that despite Mr Trump's rhetoric, there was a chance funding could be renewed in the new fiscal year. Public health officials argue that continuing to fund global health projects to stamp out infectious diseases is still in America's best interests as infections often cross borders. One executive at a major South African anti-HIV organisation said: 'Nobody wins unless we all win. No one can make it out of this alone. This is how we achieve epidemic control.' Protect yourself and your family by learning more about Global Health Security Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Popular Mineral Water Sold at Costco Recalled Over Bacterial Contamination
Popular Mineral Water Sold at Costco Recalled Over Bacterial Contamination

Yahoo

timean hour ago

  • Yahoo

Popular Mineral Water Sold at Costco Recalled Over Bacterial Contamination

Coca-Cola has issued a voluntary recall of 18-packs of 16.9-ounce glass Topo Chico mineral water due to possible contamination with Pseudomonas, a bacterium that can cause serious infections in people with weakened immune systems. The recall affects products sold between May 20 and May 29 at 40 Costco locations across five states: Arizona, Louisiana, Nevada, New Mexico, and Texas. The impacted lot is labeled '#13A2541.' No illnesses have been reported, and Coca-Cola states that the health risk is very low for the general population. Affected customers can return the product to Costco for a full you recently purchased any Topo Chico mineral water, then it's time to check your fridge or pantry. On Wednesday, Coca-Cola issued a voluntary recall of its Topo Chico mineral water in five states due to concerns about potential contamination with a deadly bacteria for individuals with weakened immune systems known as Pseudomonas. As the Centers for Disease Control and Prevention (CDC) explains, Pseudomonas is a group of bacteria that is "commonly found in the environment, like in soil and water." However, if it flourishes, it can "cause infections in the blood, lungs (pneumonia), urinary tract, or other parts of the body after surgery." A spokesperson confirmed to USA Today that the bottles were shipped to 40 retail locations across Arizona, Louisiana, Nevada, New Mexico, and Texas, with Costco included among the affected retailers. Individuals who purchased contaminated Topo Chico are encouraged to return them to their local Costco for a full refund. Those who have further questions can call Coca-Cola at 1-800-GET-COKE (1-800-438-2653). Related: The Food Recall System Is Broken, and Experts Say We're All at Risk According to the brand's letter sent to Costco members on June 2, the recalled product bears the Lot Code #13A2541 on both the outer box and the neck of each bottle. It specifically affects the 18-packs of glass 16.9-ounce Topo Chico mineral water. The notice from Coca-Cola also stated that if you purchased one of the recalled packages, you can return it to your nearest Costco for a full refund. A Costco spokesperson noted that the products were all purchased between May 20 and May 29. No illnesses have been reported in connection with the recall. Coca-Cola also noted that the health consequences for those who accidentally consume the mineral water containing pseudomonas are "very low." However, the CDC advises that those most at risk include anyone on "breathing machines, have devices such as catheters, [or] have open wounds from surgery or burns." The Cleveland Clinic additionally noted that "It's rare for a Pseudomonas aeruginosa infection to develop in people with a healthy immune system. But it can be serious and potentially deadly if you have a weakened immune system (immunocompromised)." That includes individuals living with conditions such as lupus, rheumatoid arthritis, cancer, HIV, diabetes, liver disease, or those who are pregnant. Symptoms of an infection may include fever, chills, muscle pain, earache, headache, nausea, or vomiting. If you experience any symptoms, seek out a medical expert immediately. Product recalled: 18-packs of glass 16.9-ounce Topo Chico mineral waterReason for recall: Potential Pseudomonas contaminationLot Code: #13A2541 States affected: Arizona, Louisiana, Nevada, New Mexico, and TexasStores affected: 40 separate Costco locationsRead the original article on Food & Wine

Experts Warn Of Decade-Long Setback After Trump Cuts HIV Vaccine Research
Experts Warn Of Decade-Long Setback After Trump Cuts HIV Vaccine Research

Forbes

time2 hours ago

  • Forbes

Experts Warn Of Decade-Long Setback After Trump Cuts HIV Vaccine Research

NEW YORK - DECEMBER 1: Marina Kemelman, Research Associate at the AIDS Vaccine Design and ... More Development Laboratory, collects bacteria transfected with DNA as part of research at the laboratory's campus in the former Brooklyn Army Terminal December 1, 2008 in New York City. The laboratory, seeking a vaccine to prevent the spread of AIDS, is part of the International AIDS Vaccine Initiative (or IAVI), a global not-for-profit, public-private partnership working to accelerate the development of a vaccine to prevent HIV infection and AIDS. December 1 is the 20th annual World AIDS Day around the world. (Photo by) It was a rare moment of bipartisan unity. Standing before a joint session of Congress in January 2019, President Donald Trump boldly pledged to eradicate a disease that claims one life every single minute: HIV/AIDS. 'Scientific breakthroughs have brought a once-distant dream within reach,' Trump exclaimed. 'My budget will ask Democrats and Republicans to make the needed commitment to eliminate the HIV epidemic in the United States within 10 years. We have made incredible strides.' Then, he added, 'we will defeat AIDS in America and beyond.' That was then and this is now. Last week, a group of scientists working on promising HIV vaccine studies were reportedly informed that the administration plans to revoke their research grants in a move experts warn could set the movement back years. When the global AIDS crisis peaked in the early 2000s, roughly 5,000 people were dying every single day from the disease. Thanks to the leadership of governments, the private sector, and philanthropists, the world invested more resources into the AIDS fight than ever before. This spurred nearly two decades of progress—not just against AIDS, but across global health broadly. Since 2004, AIDS-related deaths have been reduced by roughly two-thirds. But recently, progress has slowed. Covid-19 proved a major health disruption that reversed years of hard-fought gains. Efforts to reduce mother-to-child transmission rates have slowed. Global health funding is now under siege not just in the United States, but across Europe, too. And the world is no longer on track to meet critical 2030 AIDS targets. The great paradox here is that never in human history has there been more tools available to fight AIDS. The cost of antiretroviral drugs has fallen from $27 a day in 2000 to as little as 10 cents a day. Now, experts say what's needed to get the fight back on track—and eventually end the threat for good—isn't just better diagnostics and therapeutics, but long acting preventatives. Fortunately, it's an area that's seen great progress. Dubbed the 'breakthrough of the year' in 2024 by the journal Science, Gilead Science's lenacapavir is a long-acting injectable vaccine that has proven incredibly effective at preventing HIV infections. It represents a major step forward from the prevalent pre-exposure prophylaxis (PrEP) pill and mitigates some of the major privacy, stigma, and adherence issues that come with taking daily medication. The next step forward could be a vaccine with even longer immunity—one that gives patients lifetime protection. Researchers have been pursuing this laudable goal for years, but last week, the Trump administration announced plans to terminate research grants at two preeminent institutions, the Duke Human Vaccine Institute and the Scripps Research Institute, totaling $258 million. The researchers were told that the administration wanted 'to go with currently available approaches to eliminate HIV.' On the other hand, global health experts are warning that without new resources, President Trump's promise to end HIV within ten years is destined to fail—and when combined with the administration's other actions to cut and halt global health programs, HIV infections and deaths could actually rise for the first time in decades under his watch. 'I find it very disappointing that, at this critical juncture, the funding for highly successful H.I.V. vaccine research programs should be pulled,' Dennis Burton, an immunologist at Scripps, told The New York Times. Meanwhile AIDS groups, including the AIDS Vaccine Advocacy Coalition described the decision as inconceivable and shortsighted. The grant news marks the latest blow to the HIV/AIDS community, which has endured devastating domestic and global funding cuts in Trump's second term. San Francisco, which was one of the first epicenters of the domestic AIDS fight, has long relied on funding from the federal government to support community-based health programs that help reduce HIV transmission. These initiatives have helped the city make outstanding progress against the disease, but Centers for Disease Control and Prevention (CDC) grant delays have threatened testing, treatment, and care continuity. Even southern states which President Trump won decisively, and which account for 50% of all new U.S. HIV infections, have not been spared. According to the Foundation for AIDS Research (amfAR), cuts to domestic HIV prevention programs could spark over 14,000 additional deaths from AIDS-related causes and 143,000 new HIV infections. Earlier this year, HHS closed its Office of Infectious Diseases & HIV policy that quarterbacked the government's domestic AIDS response. Abroad, global health programs have fared even worse. In January, the Trump administration halted funding for The President's Emergency Plan for AIDS Relief (PEPFAR), a bipartisan program that has saved over 26 million lives. In a congressional hearing last week, Secretary of State Marco Rubio said that, '85 percent of recipients are now receiving PEPFAR services.' He also said that no one has died as a result of the aid freeze, a notion journalists and health experts scoff at. According to Brooke Nichols, an infectious disease mathematical modeler and health economist at Boston University, over 57,000 adults and 6,000 children have died as a result of the PEPFAR funding freeze and the discontinuation of global health programs. Even if those numbers are inflated, as some have contended, the number of lives needlessly lost is still likely in the tens of thousands. While some experts remain hopeful that the recent cuts will eventually be restored, the prospect of an AIDS-free future that President Trump himself once espoused appears grim. "This is a decision with consequences that will linger. This is a setback of probably a decade for HIV vaccine research," Burton warned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store